LLOYD A ROWLAND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LLOYD A ROWLAND.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LLOYD A ROWLAND. LLOYD A ROWLAND is a Vice President & General in AMYLIN PHARMACEUTICALS INC ($AMLN) and a Sr. V.P. and General Counsel in Xencor Inc ($XNCR) and a General Counsel in CytomX Therapeutics, Inc. ($CTMX).
Address: AMYLIN PHARMACEUTICALS INC 9373 TOWNE CENTRE DRIVE SAN DIEGO 92121 CA
Companies in which LLOYD A ROWLAND is an Insider
AMYLIN PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LLOYD A ROWLAND: Vice President & General
Holdings: 5,104 shares
Latest Transaction: Sep 08 2003
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LLOYD A ROWLAND: General Counsel
Holdings: 11,791 shares
Current Value: $135,597
Latest Transaction: Mar 02 2021
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Xencor Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LLOYD A ROWLAND: Sr. V.P. and General Counsel
Holdings: 1,501 shares
Current Value: $35,964
Latest Transaction: Jan 28 2016
$XNCR Market Capitalization: $977.44M
$XNCR Previous Close: $23.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of LLOYD A ROWLAND
Sentiment: All, AMLN, CTMX, XNCR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Option Exercise | A | 7.85 | 125,000 | 981,250 | 125,000 | |
| Feb 19 2020 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Option Exercise | A | 7.13 | 100,000 | 713,000 | 100,000 | |
| Jun 04 2019 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Grant | A | 8.21 | 1,812 | 14,878 | 11,791 | 10 K to 11.8 K (+18.16 %) |
| Mar 05 2019 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Buy | P | 10.33 | 9,000 | 92,970 | 9,979 | 979 to 10 K (+919.31 %) |
| Jan 29 2019 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Option Exercise | A | 16.85 | 54,900 | 925,065 | 54,900 | |
| Dec 06 2018 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Grant | A | 11.73 | 979 | 11,484 | 979 | 0 to 979 |
| Jan 28 2016 | XNCR | Xencor Inc | ROWLAND LLOYD A | Sr. V.P. and Genera ... | Option Exercise | A | 12.51 | 20,000 | 250,200 | 20,000 |